Profil
Nouhad Husseini currently holds the positions of Director & Managing Director at Checkmate Pharmaceuticals, Inc. since 2022, Director & Managing Director at Decibel Therapeutics, Inc. since 2023, and Senior VP-Business Development at Regeneron Pharmaceuticals, Inc. since 2011.
The education history includes an undergraduate degree from Princeton University and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Nouhad Husseini
| Sociétés | Poste | Début |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2011 |
| CHECKMATE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 31/05/2022 |
| DECIBEL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/09/2023 |
Formation de Nouhad Husseini
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
















